cephalexin has been researched along with 3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-7-[[1-oxo-2-(1-tetrazolyl)ethyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Motokawa, K; Murakami, K; Takasuka, M; Yoshida, T | 1 |
1 other study(ies) available for cephalexin and 3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-7-[[1-oxo-2-(1-tetrazolyl)ethyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
| Article | Year |
|---|---|
1-Oxacephalosporins: enhancement of beta-lactam reactivity and antibacterial activity.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactams; Cephalosporinase; Cephalosporins; Cephamycins; Chemical Phenomena; Chemistry; Microbial Sensitivity Tests; Moxalactam | 1981 |